Concepts (150)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Models, Statistical | 1 | 2010 | 135 | 0.350 |
Why?
|
| Pituitary Apoplexy | 1 | 2005 | 2 | 0.260 |
Why?
|
| Pituitary Neoplasms | 1 | 2005 | 21 | 0.250 |
Why?
|
| Adenoma | 1 | 2005 | 46 | 0.250 |
Why?
|
| Neovascularization, Pathologic | 2 | 2015 | 64 | 0.200 |
Why?
|
| Evoked Potentials, Somatosensory | 1 | 2016 | 10 | 0.140 |
Why?
|
| Cryosurgery | 2 | 2013 | 26 | 0.130 |
Why?
|
| Monitoring, Intraoperative | 1 | 2016 | 39 | 0.130 |
Why?
|
| Scoliosis | 1 | 2016 | 36 | 0.130 |
Why?
|
| Pancreatic Neoplasms | 2 | 2015 | 155 | 0.120 |
Why?
|
| Phagocytosis | 1 | 2015 | 52 | 0.120 |
Why?
|
| Blood Platelets | 1 | 2015 | 51 | 0.120 |
Why?
|
| Endothelial Cells | 1 | 2015 | 65 | 0.120 |
Why?
|
| Dietary Proteins | 1 | 2014 | 25 | 0.110 |
Why?
|
| Muscles | 1 | 2014 | 72 | 0.110 |
Why?
|
| Immunotherapy, Adoptive | 1 | 2013 | 5 | 0.110 |
Why?
|
| Combined Modality Therapy | 3 | 2013 | 387 | 0.110 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2013 | 33 | 0.110 |
Why?
|
| Dendritic Cells | 1 | 2013 | 59 | 0.110 |
Why?
|
| Iodine Radioisotopes | 1 | 2012 | 16 | 0.110 |
Why?
|
| Brachytherapy | 1 | 2012 | 49 | 0.100 |
Why?
|
| Optic Disk | 1 | 2012 | 3 | 0.100 |
Why?
|
| Glaucoma | 1 | 2012 | 4 | 0.100 |
Why?
|
| Retinal Ganglion Cells | 1 | 2012 | 3 | 0.100 |
Why?
|
| Optic Nerve Diseases | 1 | 2012 | 5 | 0.100 |
Why?
|
| Tomography, Optical Coherence | 1 | 2012 | 18 | 0.100 |
Why?
|
| Nerve Fibers | 1 | 2012 | 14 | 0.100 |
Why?
|
| Signal Transduction | 1 | 2015 | 498 | 0.100 |
Why?
|
| Liver Neoplasms | 1 | 2013 | 121 | 0.100 |
Why?
|
| Tyrosine-tRNA Ligase | 1 | 2011 | 2 | 0.100 |
Why?
|
| Furans | 1 | 2011 | 5 | 0.100 |
Why?
|
| Gram-Positive Bacteria | 1 | 2011 | 17 | 0.100 |
Why?
|
| Humans | 13 | 2016 | 31073 | 0.090 |
Why?
|
| Uterine Cervical Dysplasia | 1 | 2010 | 2 | 0.090 |
Why?
|
| Scleroderma, Systemic | 1 | 2010 | 18 | 0.090 |
Why?
|
| Algorithms | 1 | 2012 | 416 | 0.080 |
Why?
|
| DNA Methylation | 1 | 2010 | 132 | 0.080 |
Why?
|
| Double-Blind Method | 1 | 2010 | 499 | 0.080 |
Why?
|
| Proto-Oncogene Proteins c-met | 1 | 2009 | 4 | 0.080 |
Why?
|
| Cerebral Arteries | 1 | 2009 | 32 | 0.080 |
Why?
|
| ras Proteins | 1 | 2009 | 11 | 0.080 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2009 | 32 | 0.080 |
Why?
|
| Female | 9 | 2016 | 17017 | 0.080 |
Why?
|
| Adult | 6 | 2016 | 8950 | 0.080 |
Why?
|
| Aged | 7 | 2014 | 10082 | 0.080 |
Why?
|
| Male | 9 | 2016 | 16499 | 0.080 |
Why?
|
| Spinal Fusion | 1 | 2016 | 562 | 0.080 |
Why?
|
| ErbB Receptors | 1 | 2009 | 81 | 0.080 |
Why?
|
| Retrospective Studies | 4 | 2016 | 3665 | 0.080 |
Why?
|
| Anti-Bacterial Agents | 1 | 2011 | 420 | 0.080 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2009 | 91 | 0.080 |
Why?
|
| Middle Aged | 6 | 2014 | 10240 | 0.070 |
Why?
|
| Mutation | 1 | 2009 | 409 | 0.070 |
Why?
|
| Hypophysectomy | 1 | 2005 | 3 | 0.060 |
Why?
|
| Hormone Replacement Therapy | 1 | 2005 | 32 | 0.060 |
Why?
|
| Adolescent | 2 | 2016 | 2403 | 0.060 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2009 | 356 | 0.060 |
Why?
|
| Treatment Outcome | 3 | 2013 | 3810 | 0.060 |
Why?
|
| Neurofibrillary Tangles | 1 | 2006 | 199 | 0.060 |
Why?
|
| Substantia Nigra | 1 | 2006 | 145 | 0.060 |
Why?
|
| Coculture Techniques | 2 | 2015 | 37 | 0.060 |
Why?
|
| Gait Disorders, Neurologic | 1 | 2006 | 144 | 0.060 |
Why?
|
| Lung Neoplasms | 1 | 2009 | 691 | 0.050 |
Why?
|
| Sensitivity and Specificity | 2 | 2016 | 586 | 0.050 |
Why?
|
| Immunohistochemistry | 2 | 2015 | 430 | 0.050 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2005 | 1318 | 0.040 |
Why?
|
| Aged, 80 and over | 4 | 2012 | 5197 | 0.040 |
Why?
|
| Brain | 1 | 2009 | 1797 | 0.040 |
Why?
|
| Disease Progression | 2 | 2012 | 833 | 0.040 |
Why?
|
| Carcinoma, Squamous Cell | 2 | 2010 | 192 | 0.040 |
Why?
|
| Alzheimer Disease | 1 | 2009 | 2137 | 0.030 |
Why?
|
| Aging | 1 | 2006 | 1729 | 0.030 |
Why?
|
| Spinal Cord | 1 | 2016 | 107 | 0.030 |
Why?
|
| Umbilical Veins | 1 | 2015 | 3 | 0.030 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2015 | 29 | 0.030 |
Why?
|
| Carcinoma, Pancreatic Ductal | 1 | 2015 | 16 | 0.030 |
Why?
|
| Cell Communication | 1 | 2015 | 29 | 0.030 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2015 | 78 | 0.030 |
Why?
|
| Blotting, Western | 1 | 2015 | 178 | 0.030 |
Why?
|
| Cell Survival | 1 | 2015 | 164 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2015 | 54 | 0.030 |
Why?
|
| Malaysia | 1 | 2014 | 1 | 0.030 |
Why?
|
| India | 1 | 2014 | 21 | 0.030 |
Why?
|
| Nutrition Assessment | 1 | 2014 | 34 | 0.030 |
Why?
|
| Anthropometry | 1 | 2014 | 39 | 0.030 |
Why?
|
| China | 1 | 2014 | 57 | 0.030 |
Why?
|
| Arm | 1 | 2014 | 82 | 0.030 |
Why?
|
| Apoptosis | 1 | 2015 | 260 | 0.030 |
Why?
|
| Body Weight | 1 | 2014 | 141 | 0.030 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2013 | 190 | 0.030 |
Why?
|
| Killer Cells, Natural | 1 | 2013 | 95 | 0.030 |
Why?
|
| Neoplasm Metastasis | 1 | 2012 | 113 | 0.030 |
Why?
|
| Area Under Curve | 1 | 2012 | 70 | 0.030 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2014 | 101 | 0.030 |
Why?
|
| ROC Curve | 1 | 2012 | 145 | 0.020 |
Why?
|
| Child | 1 | 2016 | 1431 | 0.020 |
Why?
|
| Longitudinal Studies | 1 | 2016 | 1507 | 0.020 |
Why?
|
| Cells, Cultured | 1 | 2013 | 686 | 0.020 |
Why?
|
| Structure-Activity Relationship | 1 | 2011 | 43 | 0.020 |
Why?
|
| Postoperative Period | 1 | 2012 | 303 | 0.020 |
Why?
|
| Gram-Positive Bacterial Infections | 1 | 2011 | 58 | 0.020 |
Why?
|
| Cytokines | 1 | 2013 | 351 | 0.020 |
Why?
|
| Models, Molecular | 1 | 2011 | 84 | 0.020 |
Why?
|
| Body Mass Index | 1 | 2014 | 453 | 0.020 |
Why?
|
| Palliative Care | 1 | 2012 | 154 | 0.020 |
Why?
|
| Staphylococcus aureus | 1 | 2011 | 88 | 0.020 |
Why?
|
| Enzyme Inhibitors | 1 | 2011 | 144 | 0.020 |
Why?
|
| Cyclin A1 | 1 | 2010 | 1 | 0.020 |
Why?
|
| Paired Box Transcription Factors | 1 | 2010 | 2 | 0.020 |
Why?
|
| Death-Associated Protein Kinases | 1 | 2010 | 5 | 0.020 |
Why?
|
| Sulfotransferases | 1 | 2010 | 6 | 0.020 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinases | 1 | 2010 | 20 | 0.020 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2010 | 17 | 0.020 |
Why?
|
| Uterine Cervical Neoplasms | 1 | 2010 | 44 | 0.020 |
Why?
|
| Glycoproteins | 1 | 2010 | 59 | 0.020 |
Why?
|
| Mice | 1 | 2015 | 1681 | 0.020 |
Why?
|
| Young Adult | 1 | 2016 | 2061 | 0.020 |
Why?
|
| Gliosis | 1 | 2009 | 7 | 0.020 |
Why?
|
| Arterioles | 1 | 2009 | 14 | 0.020 |
Why?
|
| Logistic Models | 1 | 2010 | 411 | 0.020 |
Why?
|
| Encephalitis | 1 | 2009 | 18 | 0.020 |
Why?
|
| Microcirculation | 1 | 2009 | 42 | 0.020 |
Why?
|
| Integrin alphaVbeta3 | 1 | 2009 | 23 | 0.020 |
Why?
|
| Carcinoma, Adenosquamous | 1 | 2009 | 5 | 0.020 |
Why?
|
| Cell Count | 1 | 2009 | 98 | 0.020 |
Why?
|
| DNA, Neoplasm | 1 | 2009 | 24 | 0.020 |
Why?
|
| Staphylococcal Infections | 1 | 2011 | 185 | 0.020 |
Why?
|
| Carcinoma, Large Cell | 1 | 2009 | 17 | 0.020 |
Why?
|
| Gene Amplification | 1 | 2009 | 24 | 0.020 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 1 | 2009 | 19 | 0.020 |
Why?
|
| Blood-Brain Barrier | 1 | 2009 | 44 | 0.020 |
Why?
|
| Base Sequence | 1 | 2009 | 134 | 0.020 |
Why?
|
| Time Factors | 1 | 2013 | 1680 | 0.020 |
Why?
|
| Molecular Sequence Data | 1 | 2009 | 247 | 0.020 |
Why?
|
| Polymerase Chain Reaction | 1 | 2009 | 166 | 0.020 |
Why?
|
| Microglia | 1 | 2009 | 132 | 0.020 |
Why?
|
| Biopsy | 1 | 2009 | 249 | 0.020 |
Why?
|
| Feasibility Studies | 1 | 2009 | 244 | 0.020 |
Why?
|
| Brain Mapping | 1 | 2009 | 190 | 0.020 |
Why?
|
| Survival Rate | 1 | 2009 | 407 | 0.020 |
Why?
|
| Neoplasm Staging | 1 | 2009 | 404 | 0.020 |
Why?
|
| Adenocarcinoma | 1 | 2009 | 206 | 0.020 |
Why?
|
| Amyloid beta-Peptides | 1 | 2009 | 328 | 0.020 |
Why?
|
| Prognosis | 1 | 2009 | 924 | 0.020 |
Why?
|
| Animals | 1 | 2015 | 4720 | 0.020 |
Why?
|
| Statistics, Nonparametric | 1 | 2006 | 143 | 0.020 |
Why?
|
| Biomarkers | 1 | 2009 | 734 | 0.020 |
Why?
|
| Risk Factors | 1 | 2010 | 2591 | 0.010 |
Why?
|
| Dementia | 1 | 2006 | 561 | 0.010 |
Why?
|
| Parkinson Disease | 1 | 2006 | 1066 | 0.010 |
Why?
|